A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis

Clinical trial NCT07100938 · TERMINATED

Trial details

NCT number: NCT07100938
Sponsor: BeiGene
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2025-08-21
Primary completion: 2026-05-12
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.